Welcome to PinkRibbon Argentina
You’re not alone. This page shares key facts about common female cancers in Argentina, survival stats, health initiatives, and trusted support organisations. Our mission is to ensure every woman has access to awareness, early detection, and compassionate care.
Cancer statistics
& survival rates
Breast Cancer
Incidence: 71.3 per 100,000 women.
Mortality: 17.6 per 100,000 women.
Most common cancer and leading cause of cancer death.
5-year survival: ~90% overall.
Cervical Cancer
~4,583 new cases/year; ~2,553 deaths/year.
Age-standardized incidence: 16.7 per 100,000.
Age-standardized mortality: 8.65 per 100,000.
5-year survival: ~67%.
Ovarian Cancer
ASIR: 6.8 per 100,000.
ASMR: 4.1 per 100,000.
5-year survival: ~50%.
Endometrial (Corpus Uteri) Cancer
ASIR: 8.6 per 100,000.
ASMR: 2.1 per 100,000.
5-year survival: ~81%.
Vaginal and Vulvar Cancers
Vaginal: 0.51 per 100,000.
Vulvar: 1.40 per 100,000.
Vaginal cancer 5-year survival: ~50–60%.
Vulvar cancer 5-year survival: ~71%.
Fallopian Tube Cancer
5-year survival: ~50–70%.
Gestational Trophoblastic Disease (GTD)
High-risk GTN: 80–90% survival.
Low-risk GTN: ~100% survival.
### Systemic Challenges
High Incidence and Mortality: Significant contributor to national cancer burden.
Healthcare Inequities: Socioeconomic status and health literacy impact access to diagnosis and treatment.
Screening Participation: While coverage is high, quality and regular participation vary by region.
Resource Strain: High demand can lead to delays in treatment access.
—
Learn more
Recent research
& Initiatives
-
Recent Research
Endometrial Cancer Outcomes Study (ECHOS-A): Analyzed 2,450+ new cases, reporting 900+ deaths in 2020, highlighting disparities in treatment outcomes and need for standardized protocols.
Breast Cancer, Gender, and Body Experience: Qualitative research on Argentine women’s experiences during breast cancer treatment, exploring femininity, sexuality, and identity.Learn more
Support organizations
-
Support Organisations
Pro Mujer: Provides low-income women with healthcare access, including affordable mammograms via Mamotest partnerships; runs awareness campaigns in northern Argentina. promujer.org
Fundación Donde Quiero Estar: Offers emotional support and creative therapies in 20+ public hospitals to improve patient experience. fundaciondondequieroestar.org
Natali Dafne Flexer Foundation: Supports children/adolescents with cancer through nine centers offering free care to over 1,500 families monthly. fundacionflexer.org
Fundación María Cecilia de Ayuda al Niño Oncológico: Provides hemato-oncology services for children and adolescents in partnership with Maternal and Child Hospital of San Isidro.
Accessing cancer screening and treatment
Where to get screened
These services are part of the national screening program “Prolamvano” (meaning “I Prevent”)
Learn more
-
**Where to Get Screened**
Argentina’s Sistema de Salud Pública offers free screening services:
Breast Cancer: Mammograms available at public hospitals and health centers.
Cervical Cancer:
Ages 25–29: Cytology every 3 years.
Ages 30–64: HPV testing every 5 years.
Screening Coverage (2019 estimates):
Ages 25–65: Ever screened ~90%; screened in last 5 years ~81%.
Ages 30–49: Ever screened ~89%; screened in last 5 years ~82%.**Appointment Needed?
Yes. Book through local public hospitals or health centers.****What to Bring:**
National Identity Document (DNI)
Any prior medical records
Proof of residence if requested**Hotline Numbers:**
Ministry of Health: 0800-222-1002
PAMI (retirees/pensioners): 138 or pami.org.arLearn more
Hotline numbers
0800-222-1002
PAMI: 138
Where to get treatment
Financial support
-
**Government Schemes:**
Free cancer treatment through public hospitals for residents.
PAMI covers retirees and pensioners for comprehensive care.**Additional Support:**
Patients not in the public system should inquire about social security coverage or hospital social services.
Patients are encouraged to discuss financial assistance needs with their healthcare providers.
Need someone to talk to, anytime?
Our AI Chat is trained to support you with: